COMING SOON: Hypothesize This! – a new science podcast from UCB

Posted by
Scott Fleming, Corporate Communication
24-Feb-2025


Hypothesize This!  brings together thought leaders, researchers, and visionaries to redefine the future of drug discovery and development. Whether you're an industry professional or a science enthusiast, this podcast promises to spark curiosity and inspire innovation!

Curious about how cutting-edge innovations and bold ideas are reshaping the pharmaceutical landscape? The Hypothesize This! podcast is your gateway to unearthing the trends, theories, and challenges at the forefront of pharmaceutical research and development.

Where science meets conversation

What sets Hypothesize This! apart? Featuring guest appearances by leading voices across the industry, it’s more than a podcast – it's an exchange of ideas to make you think.
 

What you can expect

About the host
Nicola Hill is an experienced health journalist and TV presenter with more than 30 years of expertise developing a sharp instinct in uncovering compelling stories.

 

 


A sneak peek at episodes 1-3

Episode 1: The end of wet labs? How digital is virtualizing pharma research
 

Russ Altman, Professor from Stanford University and host of the Future of Everything podcast, and UCB’s Chief Scientific Officer, Alistair Henry interrogate the role of AI in revolutionizing drug discovery and experimentation
 

 

Episode 2: Within the next 10 years, will traditional clinical trials be obsolete?

Craig Lipset (Co-Chair of the Decentralized Trials and Research Alliance) and Lewis Millen (Global Clinical Science and Operations Innovation, UCB) explore the rise of decentralized clinical trials that operate invisibly in participants' daily lives, altering the future of clinical trials
 

 

Episode 3: Gene therapy’s future: will patient engagement eclipse science?
 

Emma Lane (Gene Therapy Patient Engagement Lead, UCB) and Laurence Woollard (patient advocate and Director of On the Pulse) examine why early and ongoing collaboration with patients might be the key factor driving the success of gene therapies.

 

 

Be the first to listen

Hypothesize This! will be available on Spotify and your favorite podcast platforms. Don’t miss the opportunity to stay ahead of the curve in pharmaceutical innovation.

Be sure to follow us on LinkedIn for updates, exclusive content, and a few surprises. The future of pharma starts here – Hypothesize This! is your front-row seat to the conversation.
 

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.

CAPTCHA

Enter the characters shown in the image.